Companies featured in this edition of the newsletter: ACTC, CVM, CHIP, ENZ, HYTM, IWEB, ONEZ, PHC, SIHI, SRCO

Markets continued their strong performance this week in the absence of any major market driving earnings or economic reports, as the broad based buying that characterized the previous week continued and led to gains in all of the major indices. All told, the Dow added 2.5% on the week, gaining 247 points to close at 10,270, up 17.0% on the year. The Nasdaq posted a 2.6% gain on the week, closing at 2,167 to extend its yearly gains to 37.5%, while the S&P 500 and Russell 2000 gained 2.3% and 1.0% respectively, bringing their yearly gains to 21.1% and 17.4%.

Equity markets carried the momentum from the previous week’s session, as the thin economic calendar and lack of significant earnings reports provided little incentive for investors to slow their buying activities.

Pacific Biometrics Inc. is an applied research company headquartered in Seattle, Washington. Founded in 1989, the company provides specialized central laboratory and contract research services. They offer these services to support pharmaceutical and diagnostic manufacturers who conduct human clinical trials.

As part of the Medical Laboratories and Research Industry, the company serves some of the largest pharmaceutical, biotech, and diagnostic companies in the world. Customers they have provided their services to include Pfizer, Merck, Beckman Coulter, Genzyme, Roche, Covance, and Quest Diagnostics. Pacific Biometrics Inc. trades on the OTCBB.

They provide their services, through their experts, to areas such as cardiovascular disease, diabetes, osteoporosis, arthritis, and nutrition research. Pacific Biometrics has accreditation (their PBI laboratory) from the College of American Pathologists. Through Pacific Biometrics Research Foundation, the company is one of three American members of the Centers for Disease Control (CDC) Cholesterol Reference Method Laboratory Network. Pacific Biometrics Research Foundation is a